P1.08-009 Neutrophilia as Prognostic Biomarker in Locally Advanced Stage III Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2017.09.972
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Identification of a Sixteen-microRNA Signature as Prognostic Biomarker for Stage II and III Colon Cancer

Oncotarget
Oncology
2017English

Prognostic Significance of Diabetes Mellitus in Locally Advanced Non-Small Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Leukocytosis and Neutrophilia Predict Outcome in Locally Advanced Esophageal Cancer Treated With Definitive Chemoradiation

Oncotarget
Oncology
2017English

P2.08-004 Pathologic Complete Response as an Independed Prognostic Factor in Patients With Locally Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

CDK1 Serves as a Potential Prognostic Biomarker and Target for Lung Cancer

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

CTCs as a Prognostic and Predictive Biomarker for Stage II/III Colon Cancer: A Companion Study to the PePiTA Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Preoperative BRAF Inhibition in Patients With Irresectable Locally Advanced Stage III Melanoma

Melanoma Management
DermatologyOncology
2018English

ERCC1 Is a Prognostic Biomarker in Locally Advanced Head and Neck Cancer: Results From a Randomised, Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
2013English

FDG-PET-based Prognostic Nomograms for Locally Advanced Cervical Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy